In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.
Business Of Biotech
00:00
Briansi: A Remarkable Experience
Briandi: I could pick any one molecule or therapeutic that you worked on and ask you for your just perspective on what it's like to work on something to take it all the way through. Tell us about how an experience like that, what you learn from it and how it drives your move forward. Briandi: The first few FDA meetings were really a mess, like disappointing for both sides because we were new to it. We thought we knew everything, we clearly knew a lot more than them. It was absolutely wonderful to go through there.
Transcript
Play full episode
